By proceeding, you agree to our Terms of Use and Privacy Policy.
Regulatory Science Research Policy Lead
#drugevaluation #research
#NorthAmerica
George Neyarapally works as a subject matter expert at the FDA in the Office of Surveillance and Epidemiology (OSE),Center for Drug Evaluation and Research (CDER) on regulatory science and policy
Deputy Center Director for Substance Use and Behavioral Health/ CDER
Marta Sokolowska, PhD, is the Deputy Center Director for Substance Use and Behavioral Health in FDA’s Center for Drug Evaluation and Research (CDER). She serves as the center’s executive-level leader
Director - Post Market Drug Evaluation
#healthcare #drugevaluation #pharma
TARRY AHUJA, PhD (Neuroscience) is currently the inaugural Director of the new Post-Market Drug Evaluation Program at the Canadian Agency for Drugs and Technology in Health (CADTH), the leading HTA ag